All
Combination microdrops for ROP screening: Fewer systemic adverse events than standard mydriatrics
January 3rd 2025The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.
Ophthalmic safety notice: Potential fungal contamination prompts Systane Ultra PF voluntary recall
December 27th 2024A single lot (Lot 10101) of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count, is being voluntarily recalled by Alcon Laboratories due to the detection of fungal material in a consumer-reported vial.
Study links lower socioeconomic status to increased risk of open globe injury and poorer outcomes
December 15th 2024A study investigating the impact of socioeconomic status on open globe injury (OGI) found that lower SES, measured by the Social Vulnerability Index and Distressed Communities Index, correlates with younger age, non-accidental injuries, and poorer visual outcomes in OGI patients.